Brief: Ampio Provides Update On COVID-19 Program
22/05/2020 13:13
May 22 (Reuters) - Ampio Pharmaceuticals Inc AMPE.A :
* AMPIO PROVIDES UPDATE ON COVID-19 PROGRAM
* AMPIO PHARMACEUTICALS INC - FILED INVESTIGATIVE NEW DRUG
APPLICATIONS FOR AMPION WITH FDA
* AMPIO PHARMACEUTICALS INC - MAINTAINED ONGOING DIALOG WITH
FDA
REGARDING DEVELOPMENT OF TREATMENT OPTIONS
Source text for Eikon: ID:nPncd0S6Ha
Further company coverage: AMPE.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ampio Pharmaceuticals
See all newsBrief: Ampio Announces Voluntary Delisting And SEC Deregistration
Brief: Ampio Provides Update On Results From Pre-IND Enabling Studies
Brief: Ampio Selects Ascendia Pharmaceuticals, Inc. To Provide CDMO Services To Support Clinical Development Of OA-201
Brief: Ampio Pharmaceuticals Announces Reverse Stock Split
Brief: Ampio Pharmaceuticals Inc - Holds Approximately $1.25 Million In A Deposit Account At Silicon Valley Bank